中文
Press Release
Press Release
2024 2023 2022 2021 2020 2019 2018 2017
Feb 25, 2024
FDA Grants Fast Track Designation to 9MW2821

➞
Feb 19, 2024
Mabwell Publishes the Phase III Study Results on Its Denosumab Biosimilar (MW032) in the journal JAMA Oncology

➞
Feb 18, 2024
FDA Grants Orphan Drug Designation to 9MW3011

➞
Feb 18, 2024
Mabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711

➞
Jan 31, 2024
Mabwell and Fudan University Shanghai Cancer Center Renew Strategic Cooperation Agreement

➞
Jan 04, 2024
Mabwell Established a Licensing and Commercialization Agreement for MAILISHU Indonesia Market

➞
Jan 02, 2024
Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase

➞
Previous1 2 3 4